Noonan Syndrome in South Africa: Clinical and Molecular Profiles

被引:13
|
作者
Tekendo-Ngongang, Cedrik [1 ,2 ,7 ]
Agenbag, Gloudi [1 ,2 ]
Bope, Christian Domilongo [1 ,2 ,3 ,4 ]
Esterhuizen, Alina Izabela [1 ,2 ,5 ]
Wonkam, Ambroise [1 ,2 ,6 ]
机构
[1] Univ Cape Town, Fac Hlth Sci, Dept Med, Div Human Genet, Cape Town, South Africa
[2] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Human Genet, Cape Town, South Africa
[3] Univ Kinshasa, Fac Sci, Dept Math, Kinshasa, DEM REP CONGO
[4] Univ Kinshasa, Fac Sci, Dept Comp Sci, Kinshasa, DEM REP CONGO
[5] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa
[6] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa
[7] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA
基金
英国惠康基金; 英国医学研究理事会;
关键词
Noonan syndrome; multigene panel testing; targeted next-generation sequencing; RASopathies; Ras/MAPK signaling pathway; South Africa; PARTICLE MESH EWALD; TYROSINE-PHOSPHATASE; GERMLINE MUTATIONS; RARE VARIANTS; DIAGNOSIS; FEATURES; PATHWAY; GENES; SOS2;
D O I
10.3389/fgene.2019.00333
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Noonan Syndrome (NS) is a common autosomal dominant multisystem disorder, caused by mutations in more than 10 genes in the Ras/MAPK signaling pathway. Differential mutation frequencies are observed across populations. Clinical expressions of NS are highly variable and include short stature, distinctive craniofacial dysmorphism, cardiovascular abnormalities, and developmental delay. Little is known about phenotypic specificities and molecular characteristics of NS in Africa. The present study has investigated patients with NS in Cape Town (South Africa). Clinical features were carefully documented in a total of 26 patients. Targeted Next-Generation Sequencing (NGS) was performed on 16 unrelated probands, using a multigene panel comprising 14 genes: PTPN11, SOS1, R1T1, A2ML1, BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, RAF1, SHOC2, and SPRED1. The median age at diagnosis was 4.5 years (range: 1 month-51 years). Individuals of mixed-race ancestry were most represented (53.8%), followed by black Africans (30.8%). Our cohort revealed a lower frequency of pulmonary valve stenosis (34.6%) and a less severe developmental milestones phenotype. Molecular analysis found variants predicted to be pathogenic in 5 / 16 cases (31.2%). Among these mutations, two were previously reported: MAP2K1-c.389A>G (p.Tyr130Cys) and PTPN11-c.1510A>G (p.Met504Val); three are novel: CBL-c.2520T>G (p.Cys840Trp), PTPN11- c.1496C T (p.Ser499Phe), and MAP2K1 - c.200A>C (p.Asp67A1a). Molecular dynamic simulations indicated that novel variants identified impact the stability and flexibility of their corresponding proteins. Genotype-phenotype correlations showed that clinical features of NS were more typical in patients with variants in MAP2K1. This first application of targeted NGS for the molecular diagnosis of NS in South Africans suggests that, while there is no major phenotypic difference compared to other populations, the distribution of genetic variants in NS in South Africans may be different.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Clinical and molecular study of the Noonan syndrome
    Cammarata-Scalisi, Francisco
    Neri, Giovanni
    Grazia Pomponi, Maria
    Mancano, Giorgia
    Da Silva, Gloria
    Avendano, Andrea
    Angelina Lacruz-Rengel, Maria
    Stock, Frances
    Sosa, Angel
    [J]. INVESTIGACION CLINICA, 2012, 53 (04): : 395 - 401
  • [2] Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis
    Tartaglia, M.
    Zampino, G.
    Gelb, B. D.
    [J]. MOLECULAR SYNDROMOLOGY, 2010, 1 (01) : 2 - 26
  • [3] Clinical and molecular characterization of 40 patients with Noonan syndrome
    Ferrero, Giovanni Battista
    Baldassarre, Giuseppina
    Delmonaco, Angelo Giovanni
    Biamino, Elisa
    Banaudi, Elena
    Carta, Claudio
    Rossi, Cesare
    Silengo, Margherita Cirillo
    [J]. EUROPEAN JOURNAL OF MEDICAL GENETICS, 2008, 51 (06) : 566 - 572
  • [4] Clinical and molecular analysis of Noonan syndrome in Indonesia: a case report
    Mutmainah, Iffa
    Nillesen, Willy M.
    Mundhofir, Farmaditya E. P.
    Winarni, Tri I.
    van der Burgt, Ineke
    Yntema, Helger G.
    Faradz, Sultana M. H.
    [J]. PAEDIATRICA INDONESIANA, 2016, 56 (01) : 62 - 66
  • [5] CLINICAL AND MOLECULAR STUDIES IN A LARGE DUTCH FAMILY WITH NOONAN SYNDROME
    VANDERBURGT, I
    BERENDS, E
    LOMMEN, E
    VANBEERSUM, S
    HAMEL, B
    MARIMAN, E
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 53 (02): : 187 - 191
  • [6] Neurofibromatosis-Noonan Syndrome (NFNS) - A molecular and clinical study
    Baralle, D
    Mattocks, C
    Lees, M
    ffrench-Constant, C
    Whittaker, J
    [J]. JOURNAL OF MEDICAL GENETICS, 2001, 38 : S66 - S66
  • [7] Molecular characterization of Chilean patients with a clinical diagnosis of Noonan syndrome
    Rodriguez, Fernando A.
    Unanue, Nancy
    Isabel Hernandez, Maria
    Heath, Karen E.
    Cassorla, Fernando
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (3-4): : 305 - 309
  • [8] Molecular studies on Noonan syndrome
    Jamieson, CR
    Brady, AF
    Crosby, A
    van Reen, M
    van der Burgt, I
    Mariman, E
    Kremer, H
    Patton, MA
    Jeffery, S
    [J]. GENETICS OF CARDIOPATHIES: NEW INFORMATIONS FROM MOLECULAR BIOLOGY METHODS, 1999, : 95 - 102
  • [9] Clinical and molecular characterization of a group of Spanish and German patients with Noonan syndrome
    Lopez Gonzalez, Vanesa
    Ballesta-Martinez, Mary
    Jose Sanchez-Soler, M.
    Teresa Serrano-Anton, Ana
    Glover-Lopez, Guillermo
    Ezquieta-Zubicaray, Begona
    Kuechler, Alma
    Albrecht, Beate
    Wieczorek, Dagmar
    Zorio, Esther
    Lissewski, Christina
    Zenker, Martin
    Guillen-Navarro, Encarna
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 355 - 356
  • [10] Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina
    Chinton, Josefina
    Huckstadt, Victoria
    Moresco, Angelica
    Pablo Gravina, L.
    Gabriela Obregon, M.
    [J]. ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (05): : 330 - 336